5 Pharmaceuticals for the repair, replacement and regeneration of deficient tissue and organs; biomedical preparations, biotechnological preparations, and biomedical preparations produced and modified by genetic engineering, in particular preparations of biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue; surgical implants comprising living tissue; living tissue, cells and molecules produced in vitro for replacing and/or supporting the function of absent or injured body parts; products of tissue engineering, in particular organ replacement products, namely, tissue replacement products comprising living tissue; and biological tissue intended for subsequent implantation, namely, bones, bone replacements, cartilage replacements, vessel replacements, tissue replacements, and fatty tissue replacements, all comprising living tissue